Coronavirus Update: How Much Should Remdesivir Cost?

Plus Moderna unveils vaccine manufacturing plans

US cost watchdog ICER has released its cost models for remdesivir, and says it wants to stimulate debate on how it and other COVID-19 therapies should be priced. Plus news from Amgen and ILC Therapeutics.

Barcelona_Queue_Covid19
Barcelona, ​​Spain, 2 May: people enjoying outdoor activities and exercise for the first time after seven weeks of strict lockdown. Italy and France are making similar moves as their death rates continue to decline.

Gilead Sciences Inc.’s remdesivir was given an emergency use approval on Friday 1 May by the US Food and Drug Administration, the first drug to show benefits to patients with COVID-19 and a major step forward in tackling the pandemic.

The approval was based on results from the ACTT adaptive trial released on 29 April which showed that the antiviral...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from COVID-19

More from Scrip